In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Nimotop, Nimodipine Drug Master File in Korea (Nimotop, Nimodipine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Nimotop, Nimodipine. The MFDS reviews the Nimotop, Nimodipine KDMF as part of the drug registration process and uses the information provided in the Nimotop, Nimodipine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Nimotop, Nimodipine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Nimotop, Nimodipine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Nimotop, Nimodipine suppliers with KDMF on PharmaCompass.